Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
There is a gap between the evaluation of injury prevention programmes in controlled trials and their use in real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results